Wordt geladen...

Understanding how long‐acting β(2)‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma – an update

In moderate‐to‐severe asthma, adding an inhaled long‐acting β(2)‐adenoceptor agonist (LABA) to an inhaled corticosteroid (ICS) provides better disease control than simply increasing the dose of ICS. Acting on the glucocorticoid receptor (GR, gene NR3C1), ICSs promote anti‐inflammatory/anti‐asthma ge...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Br J Pharmacol
Hoofdauteurs: Newton, Robert, Giembycz, Mark A
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2016
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5120156/
https://ncbi.nlm.nih.gov/pubmed/27646470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13628
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!